Abstract:BACKGROUNDThe main drivers of Glioblastoma (GBM) tumor growth are elevated angiogenesis and heightened characteristics of stemness. These driving factors make GBM an extremely invasive and aggressive tumor. While the GBM tumor microenvironment can be classified into several molecular subtypes, one common characteristic is the atypical induction of various signal transduction pathways including the receptor tyrosine kinases (RTKs), pro-angiogenic, and stem-cell-determining transcription factors, which all play important roles in GBM tumor formation, growth, and progression. OBJECTIVETo investigate the regulations of RTKs, pro-angiogenic, and stem-cell–determining transcription factors in two different tumor environments - monolayer cultures that induce a more differentiated state and neurosphere cultures that select for stem-like cells. METHODSNeurosphere- and monolayer-forming cell samples were cultured from four primary GBM cell lines including HK-336, HK-374, U87, and GS-154. RNA sequencing was performed at the Technology Center for Genomics and Bioinformatics at the University of California, Los Angeles. The transcriptomic data findings were validated by qPCR and western blot assays. RESULTSOur transcriptomic data revealed the significant upregulation of EGFR, PDGFR-α, VEGFA, and SOX2 in the neurosphere-forming HK-336, HK-374, U87, and GS-154 primary GBM cells. Consistent with the transcriptomic data, western blot, and qPCR assays demonstrated significantly higher expressions of these genes in the neurosphere-forming compared to the monolayer-forming GBM cells. Neurosphere-forming GBM cells possess stem-cell-like characteristics with the ability to self-renew and differentiate via the induction of various genes and disease progression pathways. CONCLUSIONSNeurosphere-forming GBM cells demonstrate upregulation of SOX2, EGFR, PDGFR-α, and VEGFA in RNA sequencing, western blot, and qPCR assays. Multipotent drug therapies designed to target multiple gene regulation pathways involving RTKs, pro-angiogenic, and stem-cell-determining transcription factors may be necessary to effectively treat GBM. Understanding the underlying mechanisms driving these aberrant cellular pathways could provide valuable insights for developing targeted therapies against this aggressive brain cancer.

Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma.

Expression of Dedifferentiation Markers and Multilineage Markers in U251 Glioblastoma Cells with Silenced EGFR and FGFR Genes.

Single-cell transcriptome analysis of lineage diversity in high-grade glioma

CD133 in Identifying Perivascular Niche of Glioma Stem Cells

A prognostic neural epigenetic signature in high-grade glioma

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

The Pathological Characteristics of Niches for Glioma Stem Cells

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

Co-expressions of Nanog gene, CD133 and GFAP in gliomas and their correlations

Prognostic Significance of Stem Cell Marker Cd133 Determined by Promoter Methylation but Not by Immunohistochemical Expression in Malignant Gliomas

Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants During Development and Gliomagenesis.

Stem-10. Neural Progenitor Cell Markers In Idh Mutant And Idhwt Gliomas

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response

Faculty Opinions Recommendation of A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma.

The single-cell make-up of adult diffuse glioma based on the 2021 WHO classification

Progenitor cells and glioma formation

Revisit the Candidacy of Brain Cell Types As the Cell(s) of Origin for Human High-Grade Glioma.

Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells

An identification of stem cell-resembling gene expression profiles in high-grade astrocytomas.

Tmic-82. Characterization Of Genetic Markers And Biological Processes Underlying The Transition Of Glioblastoma Cells From A Differentiated To A Stem-Cell-Like State

Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches.